Abstract:Vascular dysfunction has a critical role in Alzheimer's disease (AD). Recent data from brain imaging studies in humans and animal models suggest that cerebrovascular dysfunction may precede cognitive decline and onset of neurodegenerative changes in AD and AD models. Cerebral hypoperfusion and impaired amyloid beta-peptide (Abeta) clearance across the blood-brain barrier (BBB) may contribute to the onset and progression of dementia AD type. Decreased cerebral blood flow (CBF) negatively affects the synthesis of proteins required for memory and learning, and may eventually lead to neuritic injury and neuronal death. Impaired clearance of Abeta from the brain by the cells of the neurovascular unit may lead to its accumulation on blood vessels and in brain parenchyma. The accumulation of Abeta on the cerebral blood vessels, known as cerebral amyloid angiopathy (CAA), is associated with cognitive decline and is one of the hallmarks of AD pathology. CAA can severely disrupt the integrity of the blood vessel wall resulting in micro or macro intracerebral bleedings that exacerbates neurodegenerative process and inflammatory response and may lead to hemorrhagic stroke, respectively. Here, we review the role of the neurovascular unit and molecular mechanisms in vascular cells behind AD and CAA pathogenesis. First, we discuss apparent vascular changes, including the cerebral hypoperfusion and vascular degeneration that contribute to different stages of the disease process in AD individuals. We next discuss the role of the low-density lipoprotein receptor related protein-1 (LRP), a key Abeta clearance receptor at the BBB and along the cerebrovascular system, whose expression is suppressed early in AD. We also discuss how brain-derived apolipoprotein E isoforms may influence Abeta clearance across the BBB. We then review the role of two interacting transcription factors, myocardin and serum response factor, in cerebral vascular cells in controlling CBF responses and LRP-mediated Abeta clearance. Finally, we discuss the role of microglia and perivascular macrophages in Abeta clearance from the brain. The data reviewed here support an essential role of neurovascular and BBB mechanisms in contributing to both, onset and progression of AD.

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

The Role of Neurovascular System in Neurodegenerative Diseases

Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles

Endothelial Dysfunction in Neurodegenerative Diseases

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease

Decoupling of Regional Cerebral Blood Flow and Brain Function along the Alzheimer's Disease Continuum.

Vascular contributions to Alzheimer's disease

Vascular Contributions to Healthy Aging and Dementia

Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

The Pathobiology of Vascular Dementia

Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases

The Chronic Cerebral Hypoperfusion Hypothesis

The impact of cerebrovascular aging on vascular cognitive impairment and dementia

Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction

Vascular Dementia and Crosstalk Between the Complement and Coagulation Systems